Figure: Representative image of a participant who received an [18F] florbetaben PET scan, used to detect binding of amyloid protein in the brain.
Top: a structural T1 MR image, used to define anatomical regions of interest.
Middle: [18F] florbetaben PET image. Note the low PET signal in cortical gray matter, because this is a relatively cognitively normal participant.
Bottom: A fused image with the [18F] florbetaben PET image overlaid onto the structural T1 image.
Figure: Representative image of a participant who received an [18F] florbetaben PET scan, used to detect binding of amyloid protein in the brain.
Top: a structural T1 MR image, used to define anatomical regions of interest.
Middle: [18F] florbetaben PET image. Note the low PET signal in cortical gray matter, because this is a relatively cognitively normal participant.
Bottom: A fused image with the [18F] florbetaben PET image overlaid onto the structural T1 image.